National Council for Prescription Drug Programs indexing - billing unit
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Label type
- Indexing - Billing Unit
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 03:11:58
Label at a glance#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0169-3685-12 | ML - Milliliter | 0169-3685 | fb513715-528c-489c-88d7-39c4722bf43d | 1 | 2012-07-24 |
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0169-3685 | 0169-3685-12 |
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 021172 | Novolog Mix 70/30 | insulin aspart protamine and insulin aspart | 351(a) | Rx | 2026-10-01 |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NovoLog Mix 70/30 | INSULIN ASPART | Novo Nordisk Pharmaceutical Industries, LP | 1861fcee-7673-4afe-a206-08fa05c0add2 | 2023-02-28 | Warnings, Adverse reactions | 0169-3685-12 00169368512 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.